Výsledky vyhledávání - "K. J. Propert"

Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families

Autor: M, Reiff, K, Ross, S, Mulchandani, K J, Propert, R E, Pyeritz, N B, Spinner, B A, Bernhardt

Publikováno v: Clinical genetics. 83(1)

Chromosomal microarray analysis (CMA) has improved the diagnostic rate of genomic disorders in pediatric populations, but can produce uncertain and unexpected findings. This article explores clinicians' perspectives and identifies challenges in effec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3a3f7bcd5a5b5c6d4cdd5499c2834ba6
https://pubmed.ncbi.nlm.nih.gov/22989118

Zobrazit plný text záznamu

A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group

Autor: K J, Propert, A J, Schaeffer, C M, Brensinger, J W, Kusek, L M, Nyberg, J R, Landis

Publikováno v: The Journal of urology. 163(5)

We present baseline characteristics and longitudinal profiles of symptoms in the Interstitial Cystitis Data Base study, a prospective cohort study of patients with interstitial cystitis.A total of 637 eligible patients were entered into the study and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::95294d2cd2d5d0c194addfdf729885a9
https://pubmed.ncbi.nlm.nih.gov/11061916

Zobrazit plný text záznamu

Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group

Autor: E, Rovner, K J, Propert, C, Brensinger, A J, Wein, M, Foy, A, Kirkemo, J R, Landis, J W, Kusek, L M, Nyberg

Publikováno v: Urology. 56(6)

To evaluate the frequency and types of treatments reported at baseline in women who entered the Interstitial Cystitis Data Base (ICDB) cohort study.From 1993 to 1997, 581 women were enrolled and followed in the ICDB. All treatments reported at study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e0431e160f9805e8d27a836bb1007f4c
https://pubmed.ncbi.nlm.nih.gov/11113737

Zobrazit plný text záznamu

Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892)

Autor: R, Dreicer, K J, Propert, B J, Roth, L H, Einhorn, P J, Loehrer

Publikováno v: Cancer. 79(1)

This study was conducted to assess the efficacy and toxicity of vinblastine, ifosfamide, and gallium nitrate (VIG) as first-line chemotherapy in patients with locally advanced or metastatic carcinoma of the urothelium.Forty-five eligible patients wer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::078db7b23eca5c0c61b2a6c1431ff813
https://pubmed.ncbi.nlm.nih.gov/8988734

Zobrazit plný text záznamu

Expression of cell cycle-regulated proteins in prostate cancer

Autor: R D, Mashal, S, Lester, C, Corless, J P, Richie, R, Chandra, K J, Propert, A, Dutta

Publikováno v: Cancer research. 56(18)

Markers of cellular proliferation have proven to be useful prognostic markers in several tumor types. Recently, immunoreactivity for cyclins was found to provide an independent marker of tumor proliferation in breast cancer. In this study, we sought

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c226fd05699a44f1aa513c3130ece6c1
https://pubmed.ncbi.nlm.nih.gov/8797586

Zobrazit plný text záznamu

Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer

Autor: H, Kreisman, A, Lisbona, L, Olson, K J, Propert, C, Modeas, R O, Dillman, S L, Seagren, M R, Green

Publikováno v: Cancer. 72(5)

Patients with Stage III non-small cell lung cancer (NSCLC) whose cases are staged or treated surgically have different prognoses, depending on the substage (IIIa, IIIb). It is not known whether the prognostic differences apply to clinically staged no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::acf5053c017a42c82e468cdf717a7479
https://pubmed.ncbi.nlm.nih.gov/8394201

Zobrazit plný text záznamu

Carboplatin in non-small cell lung cancer: an update on the Cancer and Leukemia Group B experience

Autor: M R, Green, H, Kreisman, D C, Doll, A P, Lyss, G H, Clamon, M, Goutsou, M C, Perry, K J, Propert

Publikováno v: Seminars in oncology. 19(1 Suppl 2)

Since 1984, the Respiratory Committee of the Cancer and Leukemia Group B (CALGB) has evaluated carboplatin, either alone or in combination, in five separate phase II studies for patients with inoperable non-small cell lung cancer (NSCLC). All patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0a16a3109b6b59334510b7b13997f0e4
https://pubmed.ncbi.nlm.nih.gov/1329222

Zobrazit plný text záznamu

Interpretation of survival data in clinical trials

Autor: J R, Anderson, J J, Crowley, K J, Propert

Publikováno v: Oncology (Williston Park, N.Y.). 5(2)

The results of therapeutic interventions can often be best described through the distribution of times to some event. The most obvious example of this is actual survival (time to death) and the methods used in the analysis of "time to event" data are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ce19ba2a751019bfc6061fb5d3bf65de
https://pubmed.ncbi.nlm.nih.gov/1826203

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání